Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 12308
  • 12309
  • 12310
  • …
  • ›
  • »

2025-12-23

Vireo Growth enters California and Florida with acquisition of Eaze

2025-12-23

Red Metal steps up heap-leach tests for Qld rare earths

2025-12-23

Scentre Group brings new partner into Westfield Sydney in $864m deal

2025-12-23

Burning Rock Announces Results of 2025 Annual General Meeting

2025-12-23

Research: Citi Upgrades MAN WAH HLDGS (01999.HK) to Buy, Adds TP to $6.5

2025-12-23

Research: CMBI Recommends 3SBIO, Viewing Pharma Sector Pullback as Rebalancing of Industry Valuation & Performance

2025-12-23

Just The Facts: Kairos Minerals, Nova Minerals, Riversgold

2025-12-23

Research: CICC Recommends XINYI SOLAR/ FLAT GLASS, Expects Stabilization in PV Glass Prices & Costs Next Yr

2025-12-23

Did Old Mutual pick the exact wrong time to launch a bank?

2025-12-23

Research: CMBI Ratings, TPs on Pharmas (Table)

2025-12-23

Forte Group Holdings: Forte Group Receives BC Liquor Co-Packing Licence, Expanding Beverage Alcohol and Zero-Proof Manufacturing Capabilities at Its British Columbia Beverage Manufacturing Facility

2025-12-23

Neurizon Therapeutics Secures Over $44M in Funding to Advance HEALEY ALS Trial

  • «
  • ‹
  • …
  • 12308
  • 12309
  • 12310
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 07/Sep/2026 11:24:28
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies